{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 462100967
| IUPAC_name = 5-benzyl-2-methyl-3,4-dihydro-1''H''-pyrido[4,3-''b'']indole
| image = Mebhydrolin.svg

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|mebhydrolin}}
| pregnancy_category = Not established<ref name="Intekom">{{cite web|url=http://home.intekom.com/pharm/bayer/fabahist.html |title=FABAHISTIN 50 mg (Tablets) |date=September 1970 |accessdate=2007-03-02 |work=South African Electronic Package Inserts |deadurl=yes |archiveurl=https://web.archive.org/web/20061017085802/http://home.intekom.com/pharm/bayer/fabahist.html |archivedate=October 17, 2006 }}</ref>
| routes_of_administration = Oral<ref name="Intekom"/>

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 524-81-2
| CAS_supplemental = 6153-33-9<ref name="MeSH diazoline">{{cite web | url = http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?mode=&term=diazoline | title = Diazoline | publisher = US National Institutes of Health, National Library of Medicine | accessdate = 2007-03-02 | work = National Library of Medicine - Medical Subject Headings}}</ref>
| ATC_prefix = R06
| ATC_suffix = AX15
| PubChem = 22530
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 21129
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 9SUK9B7XVY
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08161

<!--Chemical data-->
| C=19 | H=20 | N=2
| chemical_formula_ref = <ref name="ChemIndustry">{{cite web | url = http://www.chemindustry.com/chemicals/969111.html | title = Mebhydrolin chemical information | accessdate = 2007-03-02 | work = PubChem}}</ref> 
| molecular_weight = 276.376 g/mol
| smiles = CN3Cc4c1ccccc1n(Cc2ccccc2)c4CC3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H20N2/c1-20-12-11-19-17(14-20)16-9-5-6-10-18(16)21(19)13-15-7-3-2-4-8-15/h2-10H,11-14H2,1H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = FQQIIPAOSKSOJM-UHFFFAOYSA-N
| synonyms = 9-Benzyl-2-methyl-2,3,4,9-tetrahydro-1''H''-gamma-carboline, Incidal, Omeril, Diazolin, Fabahistin, mebhydrolin napadisylate, mebhydroline 1,5-naphthalenedisulfonate<ref name="MeSH mebhydroline">{{cite web | url = http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?mode=&term=mebhydroline | title = Mebhydroline | publisher = US National Institutes of Health, National Library of Medicine | accessdate = 2007-03-02 | work = National Library of Medicine - Medical Subject Headings}}</ref>
}}

'''Mebhydrolin''' ([[International Nonproprietary Name|INN]]) or '''mebhydroline''' is an [[antihistamine]]. It is not available in the United States, but it is in various other countries under the brand names '''Bexidal''' <small>([[Bangladesh|BD]])</small> and '''Diazolin''' <small>([[Russia|RU]])</small>. It is used for symptomatic relief of allergic symptoms caused by histamine release, including nasal allergies and allergic dermatosis.

Mebhydrolin has been shown to magnify the performance-deficit effects of alcohol.<ref>{{cite journal |vauthors=Franks HM, Lawrie M, Schabinsky VV, Starmer GA, Teo RK |title=Interaction between ethanol and antihistamines: 3. mebhydrolin |journal=Med. J. Aust. |volume=2 |issue=9 |pages=477â€“9 |date=October 1981 |pmid=6119605 }}</ref>

==References==
<references />

{{Antihistamines}}
{{Histaminergics}}
{{Tricyclics}}

[[Category:H1 receptor antagonists]]


{{respiratory-system-drug-stub}}